Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  GenMark Diagnostics, Inc    GNMK

GENMARK DIAGNOSTICS, INC (GNMK)
My previous session
Most popular
  Report  
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
OFFRE
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/17/2018 09/18/2018 09/19/2018 09/20/2018 09/21/2018 Date
7.54(c) 7.64(c) 7.59(c) 7.61(c) 7.85(c) Last
141 598 319 498 116 295 307 412 767 911 Volume
-4.68% +1.33% -0.65% +0.26% +3.15% Change
More quotes
Financials (USD)
Sales 2018 71,1 M
EBIT 2018 -44,6 M
Net income 2018 -47,9 M
Debt 2018 16,0 M
Yield 2018 -
Sales 2019 89,0 M
EBIT 2019 -34,7 M
Net income 2019 -37,7 M
Debt 2019 2,00 M
Yield 2019 -
P/E ratio 2018 -
P/E ratio 2019
EV / Sales2018 6,19x
EV / Sales2019 4,79x
Capitalization 424 M
More Financials
Company
GenMark Diagnostics, Inc. is a molecular diagnostics company, which engages in the development and commercialization of proprietary eSensor electrochemical detection technology.It also manufactures, sells, and supports instruments and molecular tests.The company was founded by Jon Faiz Kayyem on... 
More about the company
Surperformance© ratings of GenMark Diagnostics, Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on GENMARK DIAGNOSTICS, INC
08/02GENMARK DIAGNOSTICS, INC. : Amendments to Articles of Inc. or Bylaws; Change in ..
AQ
07/31GENMARK DIAGNOSTICS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITIO..
AQ
07/30GENMARK DIAGNOSTICS : 2Q Earnings Snapshot
AQ
07/30GENMARK DIAGNOSTICS, INC. : Results of Operations and Financial Condition (form ..
AQ
07/30GenMark Diagnostics Reports Second Quarter 2018 Results
GL
07/30GENMARK DIAGNOSTICS, INC : GenMark Diagnostics, Inc. to Host Earnings Call
AC
07/25GENMARK DIAGNOSTICS : to Present at the Canaccord Genuity 38th Annual Growth Con..
AQ
07/16GenMark Diagnostics Schedules Second Quarter Financial Results Conference Cal..
GL
07/05GENMARK DIAGNOSTICS : Patent Issued for Capture Ligand Controls, Blocking Probes..
AQ
06/29GENMARK DIAGNOSTICS : Announces FDA Submission of its ePlex Blood Culture Identi..
AQ
More news
Sector news : Advanced Medical Equipment & Technology - NEC
09/18Exclusive - India, U.S. closing in on package deal to remove trade irritants
RE
09/07THERMO FISHER SCIENTIFIC : to Buy Becton Dickinson's Advanced Bioprocessing Unit..
DJ
09/07THERMO FISHER SCIENTIFIC : to Buy Becton Dickinson's Advanced Bioprocessing Unit
DJ
08/22Shares in hearing aid group GN Store Nord rise after outlook lift
RE
08/14AGILENT TECHNOLOGIES : Profit Beats Expectations, Guidance in Line With Wall Str..
DJ
More sector news : Advanced Medical Equipment & Technology - NEC
Latest Tweets
09/21GenMark Diagnostics $GNMK Downgraded by BidaskClub  
09/20GenMark Diagnostics $GNMK Rating Lowered to Hold at BidaskClub  
09/16$15.96 Million in Sales Expected for GenMark Diagnostics, Inc $GNMK This Quar.. 
09/13BidaskClub Lowers GenMark Diagnostics $GNMK to Buy  
09/11MOST ACTIVE ALERT: $GNMK GENMARK DIAGNOSTICS ? TradeIdeas via  
More tweets
Qtime:20
News from SeekingAlpha
09/14Canaccord bullish on medical diagnostic firms 
07/30GenMark Diagnostics, Inc. (GNMK) CEO Hany Massarany on Q2 2018 Results - Earn.. 
07/30GenMark Diagnostics misses by $0.08, beats on revenue 
07/27Med tech stocks mired in the red following Edwards, Mettler-Toledo results 
07/06GenMark Diagnostics Starting To Deliver, But Consistency Is A Key Issue 
Chart GENMARK DIAGNOSTICS, INC
Duration : Period :
GenMark Diagnostics, Inc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENMARK DIAGNOSTICS, INC
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Average target price 10,7 $
Spread / Average Target 40%
EPS Revisions
Managers
NameTitle
Hany Massarany President, Chief Executive Officer & Director
James Charles Fox Chairman
Brian Mitchell Senior Vice President-Operations
Scott Mendel CFO & Principal Accounting Office
Daryl Jay Faulkner Independent Non-Executive Director
Sector and Competitors
1st jan.Capitalization (M$)
GENMARK DIAGNOSTICS, INC88.25%424
THERMO FISHER SCIENTIFIC27.71%98 077
DANAHER CORPORATION16.32%75 630
INTUITIVE SURGICAL52.56%63 331
ILLUMINA63.93%52 650
BOSTON SCIENTIFIC CORPORATION52.36%52 233